We are live on
!
Find out more
PA
Pinnacle Associates Portfolio holdings
AUM
$9.16B
1-Year Est. Return
63.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.57%
1 Year Est. Return
+63.5%
3 Year Est. Return
+138.65%
5 Year Est. Return
+164.85%
10 Year Est. Return
+932.39%
AUM
$4.45B
AUM Growth
–
Cap. Flow
+$4.44B
Cap. Flow
% of AUM
99.87%
Top 10 Holdings %
Top 10 Hldgs %
20.21%
Holding
546
New
540
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$145M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$104M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$96.2M |
| 4 |
Las Vegas Sands
LVS
|
+$91.5M |
| 5 |
Cummins
CMI
|
+$88.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.82% |
| 2 | Communication Services | 12.17% |
| 3 | Technology | 11.91% |
| 4 | Healthcare | 11.65% |
| 5 | Energy | 7.03% |
Similar funds
LCAM
SFM
HKAM
SUT
VAS
A
IAA
AI
Pinnacle Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Pinnacle Associates, which disclosed 546 positions worth $4.45B. Its ten largest holdings account for 20% of the portfolio.
Its largest position is Regeneron Pharmaceuticals: 623,202 shares worth $140M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, followed by Communication Services and Technology.
- Pinnacle Associates's largest Q2 2013 buy was Regeneron Pharmaceuticals: 623,202 shares worth $140M.
- Pinnacle Associates's ten largest holdings make up 20% of its $4.45B portfolio in Q2 2013.
- Pinnacle Associates disclosed 546 positions in Q2 2013, its first 13F filing on record.
Based on Pinnacle Associates's 13F filing for Q2 2013, filed 13 Aug 2013.